文献速递胃肠动力与功能性疾病

系统综述与Meta分析:无麸质饮食与低FODMAP饮食治疗肠易激综合征症状的疗效评价

A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.
PubMed 文献 · Am J Gastroenterol · 2018-07-26

该系统综述与Meta分析检索MEDLINE、EMBASE、Cochrane图书馆等数据库至2017年11月,纳入9项随机对照试验。无麸质饮食与对照饮食相比全球症状无统计学显著降低(RR=0.42;95%CI 0.11至1.55;I²=88%)。低FODMAP饮食与对照干预相比全球症状降低(RR=0.69;95%CI 0.54至0.88;I²=25%),但GRADE证据质量极低。

要点

  • 无麸质饮食与对照饮食相比全球症状降低未达统计学显著(RR=0.42;95%CI 0.11至1.55;I²=88%)。
  • 低FODMAP饮食与对照干预相比全球症状降低(RR=0.69;95%CI 0.54至0.88;I²=25%)。
  • GRADE评价总体数据质量为极低,证据不足以推荐无麸质饮食改善IBS症状。

核心结论

  • 证据不足以推荐无麸质饮食用于减少肠易激综合征症状。
  • 有极低质量证据表明低FODMAP饮食对减少肠易激综合征患者症状有效。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE(1946年至2017年11月)、EMBASE(1974年至2017年11月)、Cochrane对照试验中心注册库(2017年11月)和Cochrane系统综述数据库(2005年至2017年11月)中的随机对照试验。
  • 由两名独立评价者筛选文献、评估合格性与提取数据,分歧由第三名评价者解决,采用随机效应模型合成数据,并使用GRADE方法评价证据质量。
  • 共纳入9项随机对照试验,其中无麸质饮食随机对照试验2项共111名参与者,低FODMAP饮食随机对照试验7项共397名参与者。

主要发现

  • 无麸质饮食与对照饮食相比全球症状降低未达统计学显著(RR=0.42;95%CI 0.11至1.55;I²=88%)。
  • 低FODMAP饮食与对照干预相比全球症状降低(RR=0.69;95%CI 0.54至0.88;I²=25%)。
  • 将低FODMAP饮食与严格对照饮食比较的3项随机对照试验研究间异质性最小,但效应量也最小。
  • 根据GRADE标准,总体数据质量为极低。

临床怎么用

  • 原文结论为证据不足以推荐无麸质饮食用于减少肠易激综合征症状,且有极低质量证据表明低FODMAP饮食对减少肠易激综合征患者症状有效。

局限性

  • 无麸质饮食与对照饮食比较的全球症状RR=0.42(95%CI 0.11至1.55)未达统计学显著,异质性I²=88%。
  • 根据GRADE标准,总体数据质量为极低。
  • 原文结论指出证据不足以推荐无麸质饮食用于减少肠易激综合征症状。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Dietary triggers such as gluten and highly fermentable oligo-, di- and monosaccharides and polyols (FODMAP)-containing foods have been associated with worsening irritable bowel syndrome (IBS) symptoms. However, the true impact of dietary restriction on IBS symptoms has remained unclear. The aim of this study was to conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) examining the efficacy of exclusion diets (we focused on low FODMAP and gluten-free diets (GFD)) in IBS. METHODS: We conducted a search of the literature using the electronic databases MEDLINE (1946 to November 2017), EMBASE (1974 to November 2017), Cochrane Central Register of Controlled Trials (November 2017), and Cochrane Database of Systematic Reviews (2005 to November, 2017) for RCTs of exclusion diets in IBS. Two independent reviewers screened citations and a third reviewer resolved disagreement. Two independent reviewers performed eligibility assessment and data abstraction. For inclusion, RCTs that evaluated an exclusion diet versus an alternative or usual diet and assessed improvement in either global IBS symptoms or abdominal pain were required. Data were synthesized as relative risk of symptoms remaining using a random effects model. Quality of evidence was assessed using GRADE methodology. RESULTS: A total of 1726 citations were identified. After full-text screening a total of nine studies were eligible for the systematic review. There were two RCTs of a GFD, involving 111 participants. Both selected patients who responded to a GFD and then randomized them to continue the diet or have the diet "spiked" with gluten. A GFD was associated with reduced global symptoms compared with a control diet (RR = 0.42; 95% CI 0.11 to 1.55; I2 = 88%), although this was not statistically significant. There were seven RCTs comparing a low FODMAP diet with various control interventions in 397 participants. A low FODMAP diet was associated with reduced global symptoms compared with control interventions (RR = 0.69; 95% CI 0.54 to 0.88; I2 = 25%). The three RCTS that compared low FODMAP diet with rigorous control diets had the least heterogeneity between studies, but also the least magnitude of effect. The overall quality of the data was "very low" according to GRADE criteria. CONCLUSIONS: There is insufficient evidence to recommend a GFD to reduce IBS symptoms. There is very low quality evidence that a low FODMAP diet is effective in reducing symptoms in IBS patients.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Dionne J, Ford AC, Yuan Y, et al. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. Am J Gastroenterol. 2018. PMID: 30046155. doi:10.1038/s41395-018-0195-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。